Invicta Diagnostic Fair Value
Fair Value Analysis Export
P/B Based Valuation
Asset-Based Valuation
INVICTA Fair Value Analysis — Data Sources & Coverage
Invicta Diagnostic financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit INVICTA share price screener.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
INVICTA vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Invicta Diagnostic P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| One Global Service Provi… | ONEGLOBAL | 13.34 | 8.2 | ₹872 |
| Gujarat Kidney and Super… | GKSL | 81.21 | 3.81 | ₹1,080 |
| Apollo Hospitals | APOLLOHOSP | 62.28 | 12.79 | ₹115,322 |
| Abate AS Industries | ABATEAS | 15.33 | 0.95 | ₹164 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.